Evidence map›Paper›PMID 34714533›Full record

ArticleTissue engineering and regenerative medicine2022

Electrospinning Fabrication Methods to Incorporate Laminin in Polycaprolactone for Kidney Tissue Engineering.

Büsra Baskapan, Anthony Callanan

Open access · hybridAbstract read
In one paragraph

Article in Tissue engineering and regenerative medicine, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
2.1field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 35 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Review
  6. Review
  7. Article
  8. Article
  9. Effective and new technologies in kidney tissue engineering.Frontiers in bioengineering and biotechnology · 2024
    Review
  10. Article
  11. Article
  12. Review
  13. Review
  14. Article
  15. Review
  16. Article
  17. Article
  18. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 2 institutions in 1 country.

Büsra BaskapanInstitute for Bioengineering, School of Engineering, University of Edinburgh, Faraday Building, King's Buildings, Colin Maclaurin Road, Edinburg, EH9 3DW, UK.
Anthony CallananInstitute for Bioengineering, School of Engineering, University of Edinburgh, Faraday Building, King's Buildings, Colin Maclaurin Road, Edinburg, EH9 3DW, UK. Anthony.Callanan@ed.ac.uk.ORCID 0000-0002-1871-2853
Anthony Nolan · GBUniversity of Edinburgh · GB

Funding

Medical Research Council MR/K017047/1Medical Research Council MR/L012766/1
6 · The paper itself

Abstract

backgroundToday's treatment options for renal diseases fall behind the need, as the number of patients has increased considerably over the last few decades. Tissue engineering (TE) is one avenue which may provide a new approach for renal disease treatment. This involves creating a niche where seeded cells can function in an intended way. One approach to TE is combining natural extracellular matrix proteins with synthetic polymers, which has been shown to have many positives, yet a little is understood in kidney. Herein, we investigate the incorporation of laminin into polycaprolactone electrospun scaffolds.

methodThe scaffolds were enriched with laminin via either direct blending with polymer solution or in a form of emulsion with a surfactant. Renal epithelial cells (RC-124) were cultured on scaffolds up to 21 days.

resultsMechanical characterization demonstrated that the addition of the protein changed Young's modulus of polymeric fibres. Cell viability and DNA quantification tests revealed the capability of the scaffolds to maintain cell survival up to 3 weeks in culture. Gene expression analysis indicated healthy cells via three key markers.

conclusionOur results show the importance of hybrid scaffolds for kidney tissue engineering.

Indexed as

LamininTissue EngineeringHumansKidneyPolyestersTissue ScaffoldsLamininpolycaprolactonePolyestersEmulsionKidneyLamininScaffoldTissue engineering

Identifiers

PMID34714533
PMCPMC8782962
OpenAlexW3209978662

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.